Recap: POINT Biopharma Global Q3 Earnings

POINT Biopharma Global PNT reported its Q3 earnings results on Monday, November 13, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

POINT Biopharma Global beat estimated earnings by 23.33%, reporting an EPS of $-0.23 versus an estimate of $-0.3.

Revenue was up $2.79 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 3.82% drop in the share price the next day.

To track all earnings releases for POINT Biopharma Global visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.